The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
An Assessment of the NIH Women's Health Initiative
Clinical Psychology from Rutgers University, after completing an internship at Brown University. Dr. Brownell has received numerous awards, including the Outstanding Academic Book Award from the American Library Association for Handbook of BehavioralMedicine for Women. His paper on “Understanding and Preventing Relapse” published in the American Psychologist was identified as one of the ten most frequently cited papers in psychology. Dr. Brownell has served as President of the Society of Behavioral Medicine, the Division of Health Psychology of the American Psychological Association, and the Association for the Advancement of Behavior Therapy, and has served on the Board of Directors of other organizations including the North American Association for the Study of Obesity and the Society for the Experimental Analysis of Behavior.
Gary R. Cutter, Ph.D.
Since 1991 Dr. Cutter has been the President of Pythagoras, Inc. Prior to this he was Chairman, Biostatistics and Information Systems at St. Jude Children's Research Hospital and prior to that was a Professor in the Schools of Medicine and Public Health at the University of Alabama at Birmingham. Dr. Cutter received his M.S. in 1971 and his Ph.D. in 1974 in Biometry from the University of Texas School of Public Health in Houston. Dr. Cutter has been involved with and directed numerous coordinating centers of multi-center research, the most recent being the Umbilical Artery Catheter Placement Study, the Coronary Artery Risk Development in Young Adults study, and the Contact Lens Ocular Complications Study. Dr. Cutter is a current member of several government advisory committees including the Data and Safety Monitoring Committees for the Hydroxyurea in the Treatment of Sickle Cell Disease; the Diabetes Control and Complications Trial and its Biostatistics Monitoring Group; and the Dietary Effects on Lipoproteins and Thrombogenic Activity Study. He serves as an administrator as Chairman NHLBI Special Emphasis Panel and is a member of the study section, the NHLBI Clinical Trials Review Committee. He is a member of the Research Committee of the American Sports Medicine Institute and serves on several committees for various professional associations.
John W. Farquhar, M.D.
Dr. Farquhar is the Director of the Stanford Center for Research in Disease Prevention, and is the C.F. Rehnborg Professor of Disease Prevention, and a Professor of Medicine and of Health Research and Policy at the Stanford University School of Medicine. He received his M.D. in 1952 from the University of California School of Medicine at San Francisco. Dr. Farquhar completed a residency in medicine at the University of Minnesota School of Medicine, and returned to San Francisco as a USPHS Postdoctoral Fellow in Cardiology. Dr. Farquhar took a sabbatical leave at the London School of Hygiene and Tropical Medicine in the Department of Epidemiology and Medical Statistics in 1968-69. Dr. Farquhar has received many academic honors, including the American Heart Association's Research Achievement Award in 1992. He was elected to membership in the Institute of Medicine, National Academy of Sciences in 1978.